Amalgamated Bank’s Spruce Biosciences SPRB Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRB
NHAS
OFM
RVM
RSCM
ACM
LGM
SCV
Amalgamated Bank's SPRB Position: Q2 2022 in Review
Amalgamated Bank sold out of Spruce Biosciences (SPRB) in Q2 2022, closing a stake of 14 shares — an estimated $2K sold.
Amalgamated Bank first reported a position in SPRB in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 36 funds tracked by Wall St. Rank hold SPRB as of Q2 2022.
- Amalgamated Bank reported no remaining Spruce Biosciences position as of Q2 2022 after selling out during the quarter.
- Amalgamated Bank sold 14 Spruce Biosciences shares in Q2 2022, an estimated $2K.
- Amalgamated Bank first reported a position in Spruce Biosciences in Q1 2022 and held it in 1 quarter.
- Amalgamated Bank's Spruce Biosciences position peaked at $2K in Q1 2022.
- 36 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2022.
Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.